BeStock  
Stocks › Biotechnology › MLTX

MoonLake Immunotherapeutics MLTX

US equityMarket cap rank #3205Biotechnology
$11.07 +$0.04 (+0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.07 0.00%
Open$10.79
Prev close$11.03
Day range$10.73 – $11.31
Volume1.72M
Market cap$942.13M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$35.57+221.3% vs. price
  • Buy 88%
  • Hold 13%
Low $15.00Now $11.07Avg $35.57High $57.00

Recent rating changes

The last 20 actions on file set price targets from $15.00 to $57.00, averaging $33.78.

DateFirmRatingTarget
9 Nov 2026 H.C. Wainwright BUY $50.00
6 Nov 2026 Chardan Capital BUY $57.00
5 Nov 2026 Leerink Partners BUY $30.00
4 Nov 2026 BTIG BUY $30.00
4 Nov 2026 Wedbush BUY $34.00
4 Nov 2026 RBC Capital HOLD $15.00
27 Oct 2026 RBC Capital HOLD $17.00
22 Oct 2026 Wedbush BUY $34.00
16 Oct 2026 RBC Capital HOLD $17.00
5 Oct 2026 Wedbush BUY $34.00
5 Oct 2026 H.C. Wainwright BUY $50.00
1 Oct 2026 TD Cowen BUY –
1 Oct 2026 Leerink Partners BUY $30.00
30 Sep 2026 LifeSci Capital BUY $33.00
13 Aug 2026 H.C. Wainwright BUY $50.00
10 Aug 2026 TD Cowen BUY –
10 Aug 2026 LifeSci Capital BUY $33.00
10 Aug 2026 BTIG BUY $30.00
10 Aug 2026 Wedbush BUY $34.00
10 Aug 2026 Needham BUY $30.00

Discussion

No comments yet — be the first to weigh in on MLTX.

Sign in to join the discussion.

Scroll to Top